LovelyMeds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.3/10
LovelyMeds falls below our bar on oversight: the FDA has issued it a warning letter. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked August 2026
LovelyMeds is a GLP-1 telehealth seller. The site returned a 403 to automated scraping.
Is LovelyMeds legit?
LovelyMeds is a real, operating US company, and the FDA has issued it a warning letter. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate LovelyMeds 6.3/10 overall.
Is there a LovelyMeds promo or coupon code?
We know of no promo or coupon code for LovelyMeds. Its listed price is $150 a month. Coupon sites advertising "LovelyMeds discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how LovelyMeds compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to LovelyMeds
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
LovelyMeds at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $150/mo
- What's included
- Medication · Consult
- FDA status
- 1 FDA warning letter (details below)
How LovelyMeds scores
Six columns, each one computed from something LovelyMeds has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
8.7/10$150/month is 40% below the $250 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
1.0/10The FDA has issued it a warning letter. No pharmacy is named for its prescriptions. Its price appears only after the medical intake.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.5/10The price covers the medication and clinician visits.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on LovelyMeds
Last checked August 2026- Checked the listed price across 2 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for LovelyMeds
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with LovelyMeds involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1LovelyMeds shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask LovelyMeds which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication and clinician visits.
- Lowest ongoing monthly price: semaglutide $175, tirzepatide $150. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that LovelyMeds serves your state before you start.
- The FDA has issued LovelyMeds a warning letter. It is covered in the enforcement section below; read what it alleges before you decide.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting LovelyMeds
- Phone
- +1 313 334 7322
- Hours
- Phone/chat 08:00-14:00 Mon-Fri (EST); chat 08:00-17:00 Mon-Fri; closed Sunday
Cancelling LovelyMeds
Taken from the terms LovelyMeds publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Not published by the seller
- Early-termination fee
- None
GLP-1 medications LovelyMeds offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here was read off LovelyMeds's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $175 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $150 a month, 40% below the $250 median for compounded tirzepatide across the sellers we compare
- The monthly price includes the medication and clinician visits
Against it
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued LovelyMeds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What LovelyMeds charges
LovelyMeds charges $150/month. That sits at the affordable end of what we see.
- Compounded semaglutide: $175/month
- Compounded tirzepatide: $150/month
For compounded tirzepatide, the median across the sellers we compare is $250/month, so LovelyMeds' $150 is genuinely below the middle, not just advertised that way.
SkinnyRx dispenses semaglutide and tirzepatide from $149.25/month, which makes it the fair comparison to run before you commit here.
What LovelyMeds dispenses
LovelyMeds prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that.
Safety and disclosure
Before you start an intake, ask LovelyMeds which states it serves, which pharmacy fills its prescriptions and what the monthly price includes. The FDA has issued LovelyMeds a warning letter, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. The pharmacy question matters most here because the medication is compounded. If LovelyMeds will not name the pharmacy, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether LovelyMeds bills your plan before you start.
- A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.
It fits if
- the lowest standing monthly cost is what you are solving for
Our read
LovelyMeds competes on price, and at $150/month it competes well. The FDA warning letter is what to weigh against that, not a footnote to it. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.
The Bottom Line
LovelyMeds falls below our bar on oversight: the FDA has issued it a warning letter. Read the breakdown below before you give it money.
Before you pay LovelyMeds
Starting at $150 a month. Check today's price, then start the intake.
Where LovelyMeds is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare LovelyMeds head to head
The sellers closest to LovelyMeds on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
LovelyMeds has an FDA warning letter on record, dated September 9, 2025
This letter concerns unlawful sale of unapproved and misbranded drugs to united states consumers over the internet (telehealth). A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Sources
Cited across this LovelyMeds review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See LovelyMeds's current pricing
Plans start at $150 a month. Whether you qualify is a clinician's decision, made after your intake.